These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 847240

  • 1. Effect of 15(s)15-methyl-PGF2alpha-methyl ester vaginal suppositories on circulating hormone levels in early pregnancy.
    Puri CP, Laumas V, Agarwal N, Zoremthangi, Hingorani V, Laumas KR.
    Prostaglandins; 1977 Feb; 13(2):363-73. PubMed ID: 847240
    [Abstract] [Full Text] [Related]

  • 2. Post-conceptional induction of menses with a single vaginal suppository of (15S)-15-methyl prostaglandin F2 alpha methyl ester.
    Scher J, Jeng DY, Kerenyi TD.
    Prostaglandins; 1980 Sep; 20(3):469-79. PubMed ID: 6252575
    [Abstract] [Full Text] [Related]

  • 3. Termination of very early pregnancy by vaginal suppositories-(15S)-15-methyl prostaglandin F2 alpha methyl ester.
    Wan LS, Stiber AJ, Turkel J.
    Contraception; 1981 Dec; 24(6):603-15. PubMed ID: 6173156
    [Abstract] [Full Text] [Related]

  • 4. Termination of early pregnancy by a single-dose 3.0 mg 15-methyl PGF2alpha methyl ester vaginal suppository.
    Mandelin M.
    Prostaglandins; 1978 Jul; 16(1):143-52. PubMed ID: 704921
    [Abstract] [Full Text] [Related]

  • 5. Cervical dilatation with prostaglandin analogues prior to vaginal termination of first trimester pregnancy in nulliparous patients.
    Karim SM, Choo HT, Cheng P.
    Prostaglandins; 1975 Apr; 9(4):631-8. PubMed ID: 1153813
    [Abstract] [Full Text] [Related]

  • 6. Termination of early gestation with (15S)-15-methyl prostaglandin F2 alpha methyl ester vaginal suppositories.
    Marrs RP, Brenner PF, Roy S, Mishell DR.
    Contraception; 1981 Dec; 24(6):617-30. PubMed ID: 6173157
    [Abstract] [Full Text] [Related]

  • 7. Mid-trimester abortion by vaginal administration of 9-deoxo-16, 16-dimethyl-9-methylene-PGE2.
    Bygdeman M, Christensen N, Gréen K, Lundström V.
    Contraception; 1980 Aug; 22(2):153-64. PubMed ID: 7449380
    [Abstract] [Full Text] [Related]

  • 8. Induction of abortion by vaginal administration of 15(s)15-methyl prostaglandin F2alpha methyl ester. A comparison of two delivery systems.
    Bygdeman M, Gréen K, Lundström V, Ramadan M, Fotiou S, Bergström S.
    Prostaglandins; 1976 Aug; 12 Suppl():27-51. PubMed ID: 968064
    [Abstract] [Full Text] [Related]

  • 9. Dilatation of the cervix prior to vacuum aspiration by single vaginal administration of 15-methyl-PGF2 alpha methyl ester.
    Frankman O, Bygdeman M, Gréen K, Moberg P, Sandberg CG.
    Contraception; 1980 Jun; 21(6):571-6. PubMed ID: 7428365
    [Abstract] [Full Text] [Related]

  • 10. Abortifacient efficiency of 15 (S) 15-methyl-prostaglandin F2alpha-methyl ester administered vaginally during early pregnancy.
    Ylikorkala O, Järvinen PA, Puukka M, Viinikka L.
    Prostaglandins; 1976 Oct; 12(4):609-24. PubMed ID: 973006
    [Abstract] [Full Text] [Related]

  • 11. Differences in hormonal patterns during the first postabortion menstrual cycle after two techniques of termination of pregnancy.
    Blazar AS, Harlin J, Zaidi AA, Diczfalusy E.
    Fertil Steril; 1980 May; 33(5):493-500. PubMed ID: 6768597
    [Abstract] [Full Text] [Related]

  • 12. Termination of early pregnancy by ONO-802 suppositories (16,16-dimethyl-trans-delta2-PGE1 methyl ester).
    Takagi S, Sakata H, Yoshida T, Den K, Fujii TK, Amemiya H, Tomita M.
    Prostaglandins; 1978 May; 15(5):913-9. PubMed ID: 704915
    [Abstract] [Full Text] [Related]

  • 13. Early abortion by vaginal prostaglandin suppositories. Blood loss in relation to elimination of serum chorionic gonadotrophin, progesterone and estradiol-17 beta.
    Hamberger L, Nilsson L, Björn-Rasmussen E, Atterfelt P, Wiqvist N.
    Contraception; 1978 Feb; 17(2):183-93. PubMed ID: 630888
    [Abstract] [Full Text] [Related]

  • 14. Preoperative dilatation of the cervix by single vaginal administration of 15-methyl-PGF2alpha-methyl ester.
    Ganguli AC, Gréen K, Bygdeman M.
    Prostaglandins; 1977 Oct; 14(4):779-84. PubMed ID: 339282
    [Abstract] [Full Text] [Related]

  • 15. The effect of a 15(S)-15-methyl prostaglandin F2 alpha (methyl ester) suppository upon termination of early pregnancy.
    Roux JF, Southern E, Gutknecht G.
    Contraception; 1980 Jul; 22(1):57-61. PubMed ID: 7418407
    [Abstract] [Full Text] [Related]

  • 16. Interruption of pregnancy with vaginal suppositories containing 16,16-dimethyl-trans-delta 2-prostaglandin E1 methyl ester.
    Wagatsuma T, Tabuchi T, Tabei T, Kaku R.
    Contraception; 1979 Jun; 19(6):591-7. PubMed ID: 487809
    [Abstract] [Full Text] [Related]

  • 17. Menses induction and second-trimester pregnancy termination using a polymeric controlled release vaginal delivery system containing (15S)15-methyl PGF2 alpha methyl ester.
    Bygdeman M, Christenssen N, Gréen K, Vesterqvist O, Roseman TJ, Tuttle ME, Spilman CH.
    Contraception; 1983 Feb; 27(2):141-51. PubMed ID: 6303690
    [Abstract] [Full Text] [Related]

  • 18. The vaginal administration of 9-deoxo-16,16-dimethyl-9-methylene PGE2 for second trimester abortion.
    Ballard CA.
    Contraception; 1981 Aug; 24(2):151-7. PubMed ID: 7297067
    [Abstract] [Full Text] [Related]

  • 19. Second-trimester termination with 16,16 dimethyl-PGE1-methyl ester (gemeprost), compared with a regimen that included intra-amniotic PGF2 alpha and hypertonic saline.
    Waldron KW, Renou PM, Lolatgis N, Morris ND, Mamers PM, Oldham J, Healy DL.
    Reprod Fertil Dev; 1990 Aug; 2(5):495-8. PubMed ID: 2075246
    [Abstract] [Full Text] [Related]

  • 20. The use of 16-16 dimethyl trans delta 2 PGE1 methyl ester (ONO 802) vaginal suppositories for the termination of early pregnancy. A comparative study.
    Smith SK, Baird DT.
    Br J Obstet Gynaecol; 1980 Aug; 87(8):712-7. PubMed ID: 7426533
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.